|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$104M
|
–
|
–
|
–
|
|
|
2
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$76.9M
|
–
|
–
|
–
|
|
|
3
|
Carlyle Group
Washington,
District of Columbia
|
$35.8M
|
–
|
–
|
–
|
|
|
4
|
|
$32.4M
|
-$168K
|
-16,337
|
-0.5%
|
|
|
5
|
|
$30.1M
|
+$1.86M
|
+180,993
|
+7%
|
|
|
6
|
Jennison Associates
New York
|
$28.4M
|
+$11.4M
|
+1,109,882
|
+67%
|
|
|
7
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$23.1M
|
-$362K
|
-35,172
|
-2%
|
|
|
8
|
Vanguard Group
Malvern,
Pennsylvania
|
$22.8M
|
+$2.4M
|
+232,642
|
+12%
|
|
|
9
|
NEA Management Company
Timonium,
Maryland
|
$20.2M
|
–
|
–
|
–
|
|
|
10
|
Avidity Partners Management
Dallas,
Texas
|
$16.7M
|
-$1.18M
|
-115,000
|
-7%
|
|
|
11
|
Takeda Pharmaceutical Company
Tokyo,
Japan
|
$16M
|
-$16.4M
|
-1,596,154
|
-51%
|
|
|
12
|
Gilder Gagnon Howe & Co
New York
|
$15.2M
|
+$4.68M
|
+454,642
|
+45%
|
|
|
13
|
683 Capital Management
New York
|
$14.4M
|
-$2.57M
|
-250,000
|
-15%
|
|
|
14
|
Portolan Capital Management
Boston,
Massachusetts
|
$11.6M
|
+$11.6M
|
+1,130,089
|
New
|
|
|
15
|
Checkpoint Capital
San Francisco,
California
|
$9.01M
|
+$4.43M
|
+429,839
|
+97%
|
|
|
16
|
Propel Bio Management
Los Angeles,
California
|
$8.96M
|
–
|
–
|
–
|
|
|
17
|
Decheng Capital
Menlo Park,
California
|
$8.76M
|
–
|
–
|
–
|
|
|
18
|
Kennedy Capital Management
St Louis,
Missouri
|
$8.56M
|
+$2.66M
|
+258,570
|
+45%
|
|
|
19
|
Geode Capital Management
Boston,
Massachusetts
|
$8.3M
|
+$563K
|
+54,668
|
+7%
|
|
|
20
|
Woodline Partners
San Francisco,
California
|
$8.1M
|
+$2.26M
|
+219,551
|
+39%
|
|
|
21
|
State Street
Boston,
Massachusetts
|
$8.09M
|
+$701K
|
+68,048
|
+9%
|
|
|
22
|
|
$7.85M
|
+$5.41M
|
+525,437
|
+222%
|
|
|
23
|
Catalys Pacific
Tokyo,
Japan
|
$7.44M
|
–
|
–
|
–
|
|
|
24
|
GW&K Investment Management
Boston,
Massachusetts
|
$6.18M
|
+$334K
|
+32,417
|
+6%
|
|
|
25
|
Ghost Tree Capital
New York
|
$6.18M
|
+$1.18M
|
+115,000
|
+24%
|
|
